HBV感染终末期肝病抗病毒治疗的管理
HBV감염종말기간병항병독치료적관리
Management of antiviral therapy in patients with HBV-infected end-stage liver disease
  • 万方数据
    传染病信息 전염병신식
    INFECTIOUS DISEASE INFORMATION
    2014年 2期 112-115 ,共4页

    柳芳芳%臧红%辛绍杰

    류방방%장홍%신소걸

    末期肝疾病%乙型肝炎病毒%抗病毒药 末期肝疾病%乙型肝炎病毒%抗病毒藥
    말기간질병%을형간염병독%항병독약
    end stage liver disease%hepatitis B virus%antiviral agents
    HBV持续复制是HBV感染终末期肝病进展的重要决定因素，因此对于HBV感染终末期肝病患者，应仔细询问病史及治疗反应，选择最恰当的抗病毒治疗方案。本文对HBV感染终末期肝病抗病毒治疗的管理进行综述。
    HBV지속복제시HBV감염종말기간병진전적중요결정인소，인차대우HBV감염종말기간병환자，응자세순문병사급치료반응，선택최흡당적항병독치료방안。본문대HBV감염종말기간병항병독치료적관리진행종술。
    Persistent HBV replication is the critical factor in the progression of HBV-infected end-stage liver disease, there-fore, it is important for the patients with HBV-infected end-stage liver disease to be given the most appropriate antiviral therapy in terms of the history and response to treatment. This review focuses on the management of antiviral therapy in patients with HBV-in-fected end-stage liver disease.
    원문보기 원문다운로드 사이트로이동
저자의 최근 논문